SMAD3 and inflammatory bowel disease: Indeed, IBD LPMCs contain reduced levels of phosphorylated Smad3 as compared to normal LPMCs and are unresponsive to the suppressive action of recombinant TGF-β1 in terms of cytokine production (Monteleone et al., 2001, 2004).